中文名称 | N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲 |
---|---|
中文别名 | N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲;AV-951(Tivozanib)替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N''-(5-甲基-3-异恶唑基)脲;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N-(5-甲基-3-异恶唑基)脲;Tivozanib (AV-951) 抑制剂;Tivozanib标准品;替沃扎尼;N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N`-(5-甲基-3-异恶唑基)脲 |
英文名称 | 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea |
英文别名 | N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea;Tivozanib (AV-951);1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea;1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea;Av951;AV-951;AV951 Tivozanib;Tivozanib;Tivozanib AV-951;Tivozanib(AV-951,ASP4130,KRN-951);AV951,AV-951;KRN-951;Tivozanib,AV951,AV-951;AV 951;KRN951;KRN 951;1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA;172030934T;fotivda;Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV;N-(2-C |
CAS号 | 475108-18-0 |
分子式 | C22H19CLN4O5 |
分子量 | 454.87 |